Transcatheter aortic valve implantation: restoring the qualities of life in old age
Author(s) -
Παναγιώτα Γεωργιάδου,
Eftihia Sbarouni,
George Karavolias,
Vassilis Voudris
Publication year - 2012
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afs110
Subject(s) - medicine , life expectancy , stenosis , quality of life (healthcare) , aortic valve stenosis , cardiology , intensive care medicine , population , surgery , nursing , environmental health
Transcatheter aortic valve implantation (TAVI) is a tremendous therapeutic advance for patients with severe aortic stenosis and high-surgical risk. Since TAVI-treated patients are elderly with multiple co-existing conditions, limited life expectancy and disproportionate health-care expenditures, the aspect of the health-related quality of life (HRQoL) benefits becomes of fundamental importance. Based on recent evidence, TAVI appears to improve significantly HRQoL measures compared with optimal standard care, which are restored to age-adjusted population norms over time.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom